The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...

Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease ...

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...

Donald Trump appeared to describe a dementia screening he underwent at Walter Reed Medical Center as a 'very hard' IQ test ...

President Trump has raised concerns for his mental health once again after he called a common cognitive test "very hard" ...